胡嘉, 黄钦, 黄文辉, 刘月园, 万义友, 何旺瑞, 郑建刚. 2015-2020年江西省结核病防治规划实施效果分析[J]. 疾病监测, 2023, 38(2): 157-162. DOI: 10.3784/jbjc.202206300305
引用本文: 胡嘉, 黄钦, 黄文辉, 刘月园, 万义友, 何旺瑞, 郑建刚. 2015-2020年江西省结核病防治规划实施效果分析[J]. 疾病监测, 2023, 38(2): 157-162. DOI: 10.3784/jbjc.202206300305
Hu Jia, Huang Qin, Huang Wenhui, Liu Yueyuan, Wan Yiyou, He Wangrui, Zheng Jiangang. Implementation performance of tuberculosis control and prevention in Jiangxi, 2015−2020[J]. Disease Surveillance, 2023, 38(2): 157-162. DOI: 10.3784/jbjc.202206300305
Citation: Hu Jia, Huang Qin, Huang Wenhui, Liu Yueyuan, Wan Yiyou, He Wangrui, Zheng Jiangang. Implementation performance of tuberculosis control and prevention in Jiangxi, 2015−2020[J]. Disease Surveillance, 2023, 38(2): 157-162. DOI: 10.3784/jbjc.202206300305

2015-2020年江西省结核病防治规划实施效果分析

Implementation performance of tuberculosis control and prevention in Jiangxi, 2015−2020

  • 摘要:
      目的  评价2015—2020年江西省结核病防治规划实施效果情况,为江西省“十四五”结核病防治提供科学依据。
      方法  按照《“十三五”全国结核病防治规划》终期评估调查方案,开展江西省“十三五”终期评估现场核专题调查,并收集2015—2020年结核病信息管理系统的数据。
      结果  江西省“十三五”期间政府投入经费9972.4万元,人均0.44元/人;2020年江西省结核病报告发病率为56.02/10万;肺结核患者成功治疗率为94.86%;肺结核患者和疑似肺结核患者总体到位率为98.42%;耐药肺结核高危人群筛查率为97.63%,新病原学阳性患者耐药筛查率为87.52%,利福平耐药患者接受治疗率为77.87%;市级、县级分子生物学检测能力覆盖100%;公众结核病防治核心知识知晓率为80.46%。
      结论  江西省“十三五”结核病防治规划基本实现目标,尤其耐药结核病防治和实验室建设达到既定目标。 医防合作、耐药结核病医疗保障和“互联网+”的新技术应用是江西省结核病防治面临的挑战。

     

    Abstract:
      Objective  To evaluate the effect of implementation of tuberculosis (TB) prevention and treatment plan in Jiangxi province from 2015 to 2020.
      Methods  To carry out “The 13th Five-Year” final on-site assessment and special investigation, and to collect data from TB information management system from 2015 to 2020 based on “The 13th Five-Year” Plan for National TB Prevention and Treatment’.
      Results  During period of “The 13th Five-Year”, the investment from government was 9.9724 million yuan, 0.44 yuan per capita; in 2020, reported TB incidence was 56.02/100000 in Jiangxi province; successful treatment rate in TB patients was 94.86%; overall arrival rate was 98.42% among TB patients and suspected TB patients; screening rate was 97.63% in population with high-risk of drug-resistance TB, drug-resistance screening rate was 87.52% within new pathogen-positive patients, the rate of treatment acceptance among Rifampicin-resistant patients was 77.87%; molecular biology detection capability was covered 100% on city and county level; the rate of public awareness rate of core knowledge of TB prevention and treatment was 80.46%.
      Conclusion  The goal of TB prevention and treatment plan of “The 13th Five-Year” in Jiangxi province was basically achieved, especially drug-resistant TB prevention and treatment and laboratory building were all had reached established goals. Cooperation between health facilities and CDC, drug-resistant TB medical insurance and new technique application of ‘Internet Plus’ would be the challenges for TB control and prevention in Jiangxi province.

     

/

返回文章
返回